Table 1 Combined comparator list of adult and child cardiovascular medicines extracted from 2021 WHO model list of essential medicines
Medication | Dosage form | Comments |
|---|---|---|
Adults | ||
Antianginal medicines | ||
 Bisoprolol | Tablet | Alta: metoprolol; carvedilol |
 Glyceryl trinitrate | Tablet/SLb |  |
 Isosorbide dinitrate | Tablet/SL | Class effectc |
 Verapamil | Tablet | Hydrochloride |
Antiarrhythmic medicines | ||
 Bisoprolol | Tablet | Alt: metoprolol; carvedilol |
 Digoxin | Tablet/ injection |  |
 Epinephrine | Injection | 10 ml ampoule; HCL or acid tartrate |
 Lidocaine | Injection | 5 ml ampoule; HCL |
 Verapamil | Tablet/injection | HCLd |
 Amiodarone | Tab/injection | 3 ml ampoule; HCL (comp) |
Antihypertensive medicines | ||
 Amlodipine | Tablet | Maleate, mesylate, besylate; class effect |
 Bisoprolol | Tablet | Alt: atenolol; metoprolol; carvedilol |
 Enalapril | Tablet | Hydrogen maleate; class effect |
Hydralazine | Tablet | HCL; pregnancy-induced hypertension |
 Hydrochlorothiazide | Tablet | Alt: chlorothiazide; chlorthalidone; indapamide |
 Lisinopril + amlodipine | Tablet | Single pill combination therapy; class effect |
 Lisinopril + hydrochlorothiazide (HCT) | Tablet | Single pill combination therapy; class effect |
 Losartan | Tablet | Class effect |
 Methyldopa | Tablet | Pregnancy-induced hypertension |
 Telmisartan + amlodipine | Tablet | Single pill combination therapy; class effect |
 Telmisartan + HCT | Tablet | Single pill combination therapy; class effect |
 Sodium nitroprusside | Powder for infusion | Complementary |
Heart failure medicines | Â | Â |
 Bisoprolol | Tablet | Alt: metoprolol; carvedilol |
 Digoxin | Tablet |  |
 Enalapril | Tablet | Hydrogen maleate; class effect |
 Furosemide | Tablet/injection | Class effect |
 Hydrochlorothiazide | Tablet |  |
 Losartan | Tablet | Class effect |
 Spironolactone | Tablet |  |
 Dopamine | Injection | 5 ml vial; HCL; complementary listing |
 Antithrombotic medicines | ||
Anti-platelet medicines | ||
 Acetylsalicylic acid | Tablet |  |
 Clopidogrel | Tablet |  |
Thrombolytic medicines | ||
 Alteplase | Powder for inj | Vial; complementary listing |
 Streptokinase | Powder for inj | Vial; complementary listing |
Lipid lowering agents | ||
 Simvastatin | Tablets | Use in high-risk patients; class effect |
Children | ||
Antihypertensive medication | ||
 Enalapril | Tablet | Hydrogen maleate, class effect |
 Enalapril | Suspension | Class effect |
Heart failure medicines | ||
 Digoxin | Injection | 2 ml ampoule |
 Digoxin | Oral Liquid |  |
 Digoxin | Tablet |  |
 Furosemide | Injection | 2 ml ampoule; class effect |
 Furosemide | Oral liquid |  |
 Furosemide | Tablet |  |
 Dopamine | Injection | 5 ml vial; HCL; complementary listing |